Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
George Fountzilas
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Chemicals & Drugs
Concepts & Ideas
Disorders
Geographic Areas
Sign-in to see full Profile
Network (preview)
99
Kosmidis, Paris
97
Pavlidis, Nicholas
68
Skarlos, Dimosthenis
68
Aravantinos, Gerasimos
64
Pectasides, Dimitrios
63
Samantas, Epaminondas
62
Bafaloukos, Dimitrios
48
Dimopoulos, Meletios
48
Economopoulos, Theofanis
45
Kalofonos, Haralabos
44
Kalogera-Fountzila, Anna
39
Papakostas, Pavlos
38
Gogas, Helen
30
Briasoulis, Evangelos
24
Daniilidis, John
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of George Fountzilas (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Iliadis Georgios; Selviaridis Panagiotis; Kalogera-Fountzila Anna; Fragkoulidi Anna; Baltas Dimos; Tselis Nikolaos; Chatzisotiriou Athanasios; Misailidou Despina; Zamboglou Nikolaos; Fountzilas George
The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2009;185(11):743-50.
-
2009: Briasoulis Evangelos; Pappas Periklis; Puozzo Christian; Tolis Christos; Fountzilas George; Dafni Urania; Marselos Marios; Pavlidis Nicholas
Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(20):6454-61.
-
2009: Razis Evangelia; Selviaridis Panayotis; Labropoulos Stephanos; Norris Jeremy L; Zhu Mei-Jun; Song David D; Kalebic Thea; Torrens Michael; Kalogera-Fountzila Anna; Karkavelas George; Karanastasi Sofia; Fletcher Jonathan A; Fountzilas George
Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):6258-66.
-
2009: Pectasides D; Pectasides E; Papaxoinis G; Andreadis C; Papatsibas G; Fountzilas G; Pliarchopoulou K; Macheras A; Aravantinos G; Economopoulos T
Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.
Gynecologic oncology 2009;115(1):97-101.
-
2009: Escudier Bernard; Roigas Jan; Gillessen Silke; Harmenberg Ulrika; Srinivas Sandhya; Mulder Sasja F; Fountzilas George; Peschel Christian; Flodgren Per; Maneval Edna Chow; Chen Isan; Vogelzang Nicholas J
Phase II study of sunitinib administered in a continuous once-daily dosing regimen in patients with cytokine-refractory metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4068-75.
-
2009: Mountzios G; Dimopoulos M A; Bamias A; Vourli G; Kalofonos H; Aravantinos G; Fountzilas G; Papadimitriou C A
Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1362-8.
-
2009: Armaou S; Pertesi M; Fostira F; Thodi G; Athanasopoulos P S; Kamakari S; Athanasiou A; Gogas H; Yannoukakos D; Fountzilas G; Konstantopoulou I
Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.
British journal of cancer 2009;101(1):32-7.
-
2009: Pentheroudakis George; Kalogeras Konstantine T; Wirtz Ralph M; Grimani Irene; Zografos George; Gogas Helen; Stropp Udo; Pectasides Dimitrios; Skarlos Dimosthenis; Hennig Guido; Samantas Epaminondas; Bafaloukos Dimitrios; Papakostas Pavlos; Kalofonos Haralabos P; Pavlidis Nicholas; Fountzilas George
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Breast cancer research and treatment 2009;116(1):131-43.
-
2009: Pectasides Dimitrios; Fountzilas George; Papaxoinis George; Pectasides Eirini; Xiros Nicolaos; Sykiotis Constantinos; Koumarianou Anna; Psyrri Amanda; Panayiotides John; Economopoulos Theofanis
Carboplatin and paclitaxel in metastatic or recurrent cervical cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(4):777-81.
-
2009: Fountzilas G; Dafni U; Dimopoulos M A; Koutras A; Skarlos D; Papakostas P; Gogas H; Bafaloukos D; Kalogera-Fountzila A; Samantas E; Briasoulis E; Pectasides D; Maniadakis N; Matsiakou F; Aravantinos G; Papadimitriou C; Karina M; Christodoulou C; Kosmidis P; Kalofonos H P
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.
Breast cancer research and treatment 2009;115(1):87-99.
-
2009: Pectasides D; Papaxoinis G; Fountzilas G; Aravantinos G; Bamias A; Pavlidis N; Kalofonos H P; Timotheadou E; Samantas E; Briasoulis E; Skarlos D V; Economopoulos T; Dimopoulos M A;
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Anticancer research 2009;29(2):745-51.
-
2009: Pectasides D; Papaxoinis G; Nikolaou M; Valavanis C; Aravantinos G; Fountzilas G; Tamvakis N; Pectasides E; Lekka I; Arapantoni-Dadioti P; Zizi A; Ghiconti I; Economopoulos T
Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1.
Anticancer research 2009;29(2):737-44.
-
2009: Fountzilas George; Bamias Aristotelis; Kalogera-Fountzila Anna; Karayannopoulou Georgia; Bobos Mattheos; Athanassiou Eleni; Kalogeras Konstantine T; Tolis Christos; Tsekeris Periklis; Papakostas Pavlos; Vamvouka Chrysanthi; Zaramboukas Thomas; Kosmidis Paris; Zamboglou Nikolaos; Misailidou Despina
Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck.
Anticancer research 2009;29(2):529-38.
-
2009: Pectasides Dimitrios; Dafni Urania; Bafaloukos Dimitrios; Skarlos Dimosthenis; Polyzos Aristidis; Tsoutsos Dimosthenis; Kalofonos Haralambos; Fountzilas George; Panagiotou Petros; Kokkalis George; Papadopoulos Othon; Castana Ourania; Papadopoulos Stefanos; Stavrinidis Elias; Vourli Georgia; Ioannovich John; Gogas Helen
Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(6):939-44.
-
2009: Kotoula Vassiliki; Charalambous Elpida; Biesmans Bart; Malousi Andigoni; Vrettou Eleni; Fountzilas George; Karkavelas George
Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics.
PloS one 2009;4(11):e7746.
-
2009: Pentheroudakis George; Angouridakis Nikolaos; Wirtz Ralph; Nikolaou Angelos; Kalogeras Konstantine T; Pavlidis Nicholas; Fountzilas George
Transcriptional activity of human epidermal growth factor receptor family and angiogenesis effectors in locoregionally recurrent head and neck squamous cell carcinoma and correlation with patient outcome.
Journal of oncology 2009;2009():854127.
-
2009: Kostopoulos Ioannis; Karavasilis Vasilios; Karina Maria; Bobos Mattheos; Xiros Nikolaos; Pentheroudakis George; Kafiri Georgia; Papakostas Pavlos; Vrettou Eleni; Fountzilas George
Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.
BMC cancer 2009;9():339.
-
2009: Papadimitriou Christos A; Kalofonos Haralambos; Zagouri Flora; Papakostas Pavlos; Bozas George; Makatsoris Thomas; Dimopoulos Meletios-A; Fountzilas George
Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.
Oncology 2009;77(3-4):212-6.
-
2009: Skarlos Dimosthenis V; Timotheadou Eleni; Galani Eleni; Samantas Epaminondas; Grimani Irene; Lianos Evangelos; Aravantinos Gerasimos; Xanthakis Ioannis; Pentheroudakis George; Pectasides Dimitrios; Fountzilas George
Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group.
Oncology 2009;77(2):107-12.
-
2009: Christodoulou Christos; Kostopoulos Ioannis; Kalofonos Haralabos P; Lianos Evangelos; Bobos Mattheos; Briasoulis Evangelos; Gogas Helen; Razis Evangelia; Skarlos Dimosthenis V; Fountzilas George;
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
Oncology 2009;76(4):275-85.
-
2008: Koutras A K; Kalogeras K T; Dimopoulos M-A; Wirtz R M; Dafni U; Briasoulis E; Pectasides D; Gogas H; Christodoulou C; Aravantinos G; Zografos G; Timotheadou E; Papakostas P; Linardou H; Razis E; Economopoulos T; Kalofonos H P; Fountzilas G;
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
British journal of cancer 2008;99(11):1775-85.
-
2008: Lazaridis George; Pentheroudakis George; Fountzilas George; Pavlidis Nicholas
Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
Cancer treatment reviews 2008;34(8):693-700.
-
2008: Fountzilas George; Bobos Mattheos; Kalogera-Fountzila Anna; Xiros Nikolaos; Murray Samuel; Linardou Helena; Karayannopoulou Georgia; Koutras Angelos K; Bafaloukos Dimitrios; Samantas Epaminondas; Christodoulou Christos; Economopoulos Theofanis; Kalogeras Konstantine T; Kosmidis Paris
Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation.
Cancer investigation 2008;26(8):784-93.
-
2008: Aravantinos Gerasimos; Fountzilas George; Bamias Aristotelis; Grimani Irene; Rizos Spyridon; Kalofonos Haralabos P; Skarlos Dimosthenis V; Economopoulos Theofanis; Kosmidis Paris A; Stathopoulos George P; Briasoulis Evangelos; Pectasides Dimitrios; Samantas Epaminondas; Timotheadou Eleni; Papadimitriou Christos; Papanikolaou Alexandros; Onyenadum Adimchi; Papakostas Pavlos; Bafaloukos Dimitrios; Dimopoulos Meletios A;
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2169-77.
-
2008: Papadimitriou Christos A; Fountzilas George; Bafaloukos Dimitrios; Bozas George; Kalofonos Haralambos; Pectasides Dimitrios; Aravantinos Gerassimos; Bamias Aristotelis; Dimopoulos Meletios-A;
Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Gynecologic oncology 2008;111(1):27-34.
-
2008: Koutras Angelos K; Fountzilas George; Dafni Urania; Dimopoulos Meletios A; Pectasides Dimitrios; Klouvas George; Papakostas Pavlos; Kosmidis Paris; Samantas Epaminondas; Gogas Helen; Briasoulis Evangelos; Vourli Georgia; Petsas Theodoros; Xiros Nikolaos; Kalofonos Haralabos P;
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.
Anticancer research 2008;28(5B):2913-20.
-
2008: Kalofonos H P; Bamias A; Koutras A; Papakostas P; Basdanis G; Samantas E; Karina M; Misailidou D; Pisanidis N; Pentheroudakis G; Economopoulos T; Papadimitriou C; Skarlos D V; Pectasides D; Stavropoulos M; Bafaloukos D; Kardamakis D; Karanikiotis C; Vourli G; Fountzilas G;
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study.
European journal of cancer (Oxford, England : 1990) 2008;44(12):1693-700.
-
2008: Mauri Davide; Tzachanis Dimitrios; Tsekoura Panagiota; Xanthakis Ioannis; Tsali Lamprini; Roumbkou Sofia; Fountzilas George
Weekly docetaxel regimens and radiation pneumonitis.
The journal of supportive oncology 2008;6(6):265-6.
-
2008: Papadimitriou Christos A; Bafaloukos Dimitrios; Bozas George; Kalofonos Haralambos; Kosmidis Paris; Aravantinos Gerassimos; Fountzilas George; Dimopoulos Meletios-A;
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Gynecologic oncology 2008;110(1):87-92.
-
2008: Anagnostopoulos Theodore; Pertesi Maroulio; Konstantopoulou Irene; Armaou Sofia; Kamakari Smaragda; Nasioulas George; Athanasiou Athanassios; Dobrovic Alex; Young Mary-Anne; Goldgar David; Fountzilas George; Yannoukakos Drakoulis
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.
Breast cancer research and treatment 2008;110(2):377-85.
-
2008: Briasoulis E; Fountzilas G; Bamias A; Dimopoulos M A; Xiros N; Aravantinos G; Samantas E; Kalofonos H; Makatsoris T; Mylonakis N; Papakostas P; Skarlos D; Varthalitis I; Pavlidis N
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Cancer chemotherapy and pharmacology 2008;62(2):277-84.
-
2008: Dahabreh Issa J; Linardou Helen; Siannis Fotios; Fountzilas George; Murray Samuel
Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials.
The oncologist 2008;13(6):620-30.
-
2008: Papadimitriou Christos A; Papakostas Pavlos; Timotheadou Eleni; Aravantinos Gerasimos; Bamias Aristotelis; Fountzilas George
Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
Cancer investigation 2008;26(5):491-8.
-
2008: Karanikiotis Charisios; Daniilidis Michail; Karyotis Nikolaos; Bakogiannis Charalambos; Economopoulos Theofanis; Murray Samuel; Papamichael Demetris; Samantas Epaminondas; Nikolaou Angelos; Skoura Lemonia; Tselis Nikolaos; Zamboglou Nikolaos; Fountzilas George
HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2008;184(6):325-31.
-
2008: Pentheroudakis George; Fountzilas George; Kalofonos Haralabos P; Golfinopoulos Vassilios; Aravantinos Gerasimos; Bafaloukos Dimitrios; Papakostas Pavlos; Pectasides Dimitrios; Christodoulou Christos; Syrigos Konstantinos; Economopoulos Theofanis; Pavlidis Nicholas;
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Critical reviews in oncology/hematology 2008;66(3):237-47.
-
2008: Pectasides D; Xiros N; Papaxoinis G; Pectasides E; Sykiotis C; Koumarianou A; Psyrri A; Gaglia A; Kassanos D; Gouveris P; Panayiotidis J; Fountzilas G; Economopoulos T
Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
Gynecologic oncology 2008;109(2):250-4.
-
2008: Fountzilas G; Dafni U; Gogas H; Linardou H; Kalofonos H P; Briasoulis E; Pectasides D; Samantas E; Bafaloukos D; Stathopoulos G P; Karina M; Papadimitriou C; Skarlos D; Pisanidis N; Papakostas P; Markopoulos C; Tzorakoeleftherakis E; Dimitrakakis K; Makrantonakis P; Xiros N; Polichronis A; Varthalitis I; Karanikiotis C; Dimopoulos A M;
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):853-60.
-
2008: Papaxoinis G; Fountzilas G; Rontogianni D; Dimopoulos M A; Pavlidis N; Tsatalas C; Pectasides D; Xiros N; Economopoulos T
Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(4):780-6.
-
2008: Pectasides D; Papaxoinis G; Fountzilas G; Aravantinos G; Pectasides E; Mouratidou D; Economopoulos T; Andreadis Ch
Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Anticancer research 2008;28(2B):1421-7.
-
2008: Konstantopoulou Irene; Rampias Theodore; Ladopoulou Angela; Koutsodontis George; Armaou Sophia; Anagnostopoulos Theodore; Nikolopoulos George; Kamakari Smaragda; Nounesis George; Stylianakis Antonis; Karanikiotis Charisios; Razis Evangelia; Gogas Helen; Keramopoulos Antonios; Gaki Vassiliki; Markopoulos Christos; Skarlos Dimosthenis; Pandis Nikos; Bei Thalia; Arzimanoglou Iordanis; Fountzilas George; Yannoukakos Drakoulis
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.
Breast cancer research and treatment 2008;107(3):431-41.
-
2008: Economopoulos Theofanis; Psyrri Amanda; Fountzilas George; Tsatalas Constantinos; Anagnostopoulos Athanasios; Papageorgiou Sotirios; Xiros Nikolaos; Dimopoulos Meletios Athanasios
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma.
Leukemia & lymphoma 2008;49(1):68-74.
-
2008: Kosmidis P A; Kalofonos H P; Christodoulou C; Syrigos K; Makatsoris T; Skarlos D; Bakogiannis C; Nicolaides C; Bafaloukos D; Bamias A; Samantas E; Xiros N; Boukovinas I; Fountzilas G; Dimopoulos M A
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):115-22.
-
2008: Razis Evangelia; Briasoulis Evangelos; Vrettou Eleni; Skarlos Dimosthenis V; Papamichael Dimitrios; Kostopoulos Ioannis; Samantas Epaminontas; Xanthakis Ioannis; Bobos Mattheos; Galanidi Eleni; Bai Maria; Gikonti Ioanna; Koukouma Alona; Kafiri Georgia; Papakostas Pavlos; Kalogeras Konstantine T; Kosmidis Paris; Fountzilas George
Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study.
BMC cancer 2008;8():234.
-
2008: Pentheroudakis George; Briasoulis Evangelos; Kalofonos Haralambos P; Fountzilas Georgios; Economopoulos Theofanis; Samelis George; Koutras Aris; Karina Maria; Xiros Nikolaos; Samantas Epameinondas; Bamias Aristotelis; Pavlidis Nikolaos;
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1148-55.
-
2007: Pectasides D; Samantas E; Fountzilas G; Briasoulis E; Kosmidis P; Skarlos D; Dimopoulos M A; Kalofonos H P; Economopoulos T; Syrigos K
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group.
Lung cancer (Amsterdam, Netherlands) 2007;58(3):355-61.
-
2007: Timotheadou Eleni; Skarlos Dimosthenis-Vasilios; Samantas Epaminondas; Papadopoulos Savvas; Murray Sam; Skrickova Jana; Christodoulou Christos; Papakostantinou Christos; Pectasides Dimitrios; Papakostas Pavlos; Kaplanova Jana; Vrettou Eleni; Karina Maria; Kosmidis Paraskevas; Fountzilas George
Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
Anticancer research 2007;27(6C):4481-9.
-
2007: Pectasides D; Dafni U; Aravantinos G; Timotheadou E; Skarlos D V; Pavlidis N; Gaglia A; Kalofonos H P; Fountzilas G
A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin.
Anticancer research 2007;27(6C):4411-7.
-
2007: Kosmidis P; Fountzilas G; Baka S; Samantas E; Dimopoulos A M; Gogas H; Skarlos D; Papacostas P; Boukovinas J; Bakogiannis Ch; Pantelakos P; Athanasiou H; Misailidou D; Tsekeris P; Pavlidis N
Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
Anticancer research 2007;27(6C):4391-5.
-
2007: Onyenadum A; Gogas H; Markopoulos C; Bafaloukos D; Aravantinos G; Mantzourani M; Koutras A; Tzorakoelefterakis E; Xiros N; Makatsoris T; Fountzilas G; Kalofonos H P
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
Journal of chemotherapy (Florence, Italy) 2007;19(5):582-9.
-
2007: Papadopoulos Savvas; Kouvatseas George; Skarlos Dimosthenis; Malamos Nikolaos; Delliou Eleftheria; Saratsiotou Ioanna; Ardavanis Alexandros; Mavroudis Dimitrios; Skarpidi Evangelia; Arapantoni Petroula; Karyda Irini; Patakioyta Frideriki; Aravantinos Gerasimos; Razis Evangelia; Fountzilas George; Kosmidis Paris
Comparison of HER2 detection methods between central and regional laboratories in Greece.
Clinical breast cancer 2007;7(10):784-90.
-
2007: Tselis Nikolaos; Kolotas Christos; Birn Gerhard; Röddiger Sandra; Filipowicz Ineza; Kontova Marina; Fountzilas George; Selviaridis Panayiotis; Baltas Dimos; Heyd Reinhard; Anagnostopoulos Georgios; Zamboglou Nikolaos
CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(10):563-70.
-
2007: Pentheroudakis G; Pappas P; Golfinopoulos V; Fountzilas G; Nikolaidou M; Boumba V A; Vougiouklakis T; Nikiforidis L; Tzamakou E; Siarabi O; Marselos M; Pavlidis N
Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy.
Cancer chemotherapy and pharmacology 2007;60(5):733-9.
-
2007: Economopoulos T; Psyrri A; Dimopoulos M A; Kalogera-Fountzila A; Pavlidis N; Tsatalas C; Nikolaides C; Mellou S; Xiros N; Fountzilas G
CEOP-21 versus CEOP-14 chemotherapy with or without rituximab for the first-line treatment of patients with aggressive lymphomas: results of the HE22A99 trial of the Hellenic Cooperative Oncology Group.
Cancer journal (Sudbury, Mass.) 2007;13(5):327-34.
-
2007: Skarlos Dimosthenis V; Bai Maria; Goussia Anna; Samantas Epaminontas; Galani Eleni; Tsavdaridis Dimitrios; Karina Maria; Papakostas Pavlos; Konstantara Athina; Fountzilas George
Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group.
Anticancer research 2007;27(4C):2973-83.
-
2007: Nikolaou M; Valavanis C; Aravantinos G; Fountzilas G; Tamvakis N; Lekka I; Arapantoni-Dadioti P; Zizi A; Ghiconti I; Economopoulos Th; Pectasides D
Kit expression in male germ cell tumors.
Anticancer research 2007;27(3B):1685-8.
-
2007: Malamou-Mitsi Vassiliki; Crikoni Olga; Timotheadou Eleni; Aravantinos Gerassimos; Vrettou Eleni; Agnantis Niki; Fountzilas George
Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer.
Anticancer research 2007;27(2):1157-65.
-
2007: Kosmidis Paris A; Dimopoulos Meletios-Athanasios; Syrigos Konstantinos; Nicolaides Costas; Aravantinos Gerasimos; Boukovinas Ioannis; Pectasides Dimitrios; Fountzilas George; Bafaloukos Dimitrios; Bacoyiannis Charalampos; Kalofonos Haralampos P
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(2):135-40.
-
2007: Kolotas Christos; Tselis Nikolaos; Sommerlad Manon; Röddiger Sandra; Schnabel Thomas; Baltas Dimos; Kalogera-Fountzila Anna; Fountzilas George; Zamboglou Nikolaos
Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2007;183(2):69-75.
-
2007: Pectasides D; Valavanis C; Nikolaou M; Aravantinos G; Lekka I; Skarlos D; Kalofonos Ch; Fountzilas G; Kostopoulou V; Zizi A; Economopoulos Th; Arapantoni-Datioti P
Molecular markers in extragonadal germ cell tumours: a matched case-control study.
Histopathology 2007;50(3):394-6.
-
2007: Armaou Sophia; Konstantopoulou Irene; Anagnostopoulos Theodore; Razis Evangelia; Boukovinas Ioannis; Xenidis Nikolaos; Fountzilas George; Yannoukakos Drakoulis
Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
European journal of cancer (Oxford, England : 1990) 2007;43(2):443-53.
-
2007: Tzaida Olympia; Gogas Helen; Dafni Urania; Kyroudi Aspasia; Papaspyrou Irene; Kyriakou Vasiliki; Malamou-Mitsi Vasiliki; Alamani Maria; Skopa Chrisoula; Kostopoulos Ioannis; Kastritis Efstathios; Pectasides Dimitrios; Briasoulis Evangelos; Kalofonos Haralabos P; Aravantinos Gerasimos; Fountzilas George; Arapantoni-Dadioti Petroula
Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Oncology 2007;72(5-6):388-96.
-
2007: Pectasides D; Papaxoinis G; Pectasides E; Galani H; Razi E; Katodrytis N; Fountzilas G; Economopoulos T
Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the Hellenic Cooperative Oncology Group.
Oncology 2007;72(3-4):211-8.
-
2007: Makatsoris Thomas; Papakostas Pavlos; Kalofonos Haralabos P; Xanthakis Ioannis; Tsavdaridis Dimitrios; Aravantinos Gerasimos; Gogas Helen; Klouvas George; Kosmidis Paris; Pectasides Dimitrios; Fountzilas George
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.
Medical oncology (Northwood, London, England) 2007;24(3):301-7.
-
2007: Dova Leukothea; Pentheroudakis George; Georgiou Ioannis; Malamou-Mitsi Vassiliki; Vartholomatos George; Fountzilas George; Kolaitis Nikolaos; Kitsiou Evangelia; Pavlidis Nicholas
Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target?
Clinical & experimental metastasis 2007;24(2):79-86.
-
2006: Gogas H; Polyzos A; Stavrinidis I; Frangia K; Tsoutsos D; Panagiotou P; Markopoulos C; Papadopoulos O; Pectasides D; Mantzourani M; Middleton M; Vaiopoulos G; Fountzilas G
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1835-41.
-
2006: Fountzilas George; Karkavelas George; Kalogera-Fountzila Anna; Karina Maria; Ignatiadis Michail; Koukoulis George; Plataniotis George; Misailidou Despina; Bobos Mattheos; Pectasides Dimitrios; Razis Evangelia; Karavelis Antonios; Selviaridis Panagiotis
Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation.
Anticancer research 2006;26(6C):4675-86.
-
2006: Kostadima Lida; Pentheroudakis George; Fountzilas George; Dimopoulos Meletios; Pectasides Dimitrios; Gogas Helen; Stropp Udo; Christodoulou Christos; Samantas Epameinondas; Wirtz Ralph; Hennig Guido; Bafaloukos Dimitrios; Arapantoni P; Kalofonos Haralambos; Papakostas Pavlos; Economopoulos Theofanis; Bamias Aristotelis; Pavlidis Nicholas
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival.
Breast cancer research and treatment 2006;100(2):161-7.
-
2006: Papaxoinis George; Papageorgiou Sotirios; Rontogianni Dimitra; Kaloutsi Vassiliki; Fountzilas George; Pavlidis Nikolaos; Dimopoulos Meletios; Tsatalas Constantinos; Xiros Nikolaos; Economopoulos Theofanis
Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG).
Leukemia & lymphoma 2006;47(10):2140-6.
-
2006: Malamou-Mitsi V; Gogas H; Dafni U; Bourli A; Fillipidis T; Sotiropoulou M; Vlachodimitropoulos D; Papadopoulos S; Tzaida O; Kafiri G; Kyriakou V; Markaki S; Papaspyrou I; Karagianni E; Pavlakis K; Toliou T; Scopa Cd; Papakostas P; Bafaloukos D; Christodoulou C; Fountzilas G
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1504-11.
-
2006: Fountzilas G; Papakostas P; Dafni U; Makatsoris T; Karina M; Kalogera-Fountzila A; Maniadakis N; Aravantinos G; Syrigos K; Bamias A; Christodoulou C; Economopoulos T; Kalofonos Hp; Nikolaou A; Angouridakis N; Stathopoulos G; Bafaloukos D; Pavlidis N; Daniilidis J
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1560-7.
-
2006: Razis Evangelia; Karina Maria; Karanastassi Sofia; Fountzilas George
Three case reports of hand-foot syndrome with gefitinib.
Cancer investigation 2006;24(5):514-6.
-
2006: Kalogera-Fountzila Anna; Karanikolas Dimitrios; Katodritis Nikos; Samantas Epaminodas; Sarafopoulos Apostolos; Ikonomou Ippoliti; Zamboglou Nikolaos; Tselis Nikolaos; Dimitriadis Athanassios-Sokratis; Fountzilas George;
Prognostic factors and significance of the revised 6th edition of the AJCC classification in patients with locally advanced nasopharyngeal carcinoma.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2006;182(8):458-66.
-
2006: Pectasides Dimitrios; Fountzilas George; Aravantinos Gerassimos; Kalofonos Charalambos; Efstathiou Helen; Farmakis Dimitrios; Skarlos Dimosthenes; Pavlidis Nikolaos; Economopoulos Theofanis; Dimopoulos Meletios A
Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2006;102(2):285-91.
-
2006: Pentheroudakis George; Neanidis Konstantinos; Kostadima Lida; Fountzilas George; Pavlidis Nicholas
Elderly patients with squamous lung carcinoma: faring better or worse?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(8):867-70.
-
2006: Mauri D; Pentheroudakis G; Bafaloukos D; Pectasides D; Samantas E; Efstathiou E; Kalofonos H P; Syrigos K; Klouvas G; Papakostas P; Kosmidis P; Fountzilas G; Pavlidis N;
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
Anticancer research 2006;26(4B):3175-81.
-
2006: Psyrri Amanda; Fountzilas George
Can the standard chemotherapeutic regimen be improved upon for small-cell lung cancer?
Nature clinical practice. Oncology 2006;3(7):360-1.
-
2006: Pentheroudakis George; Fountzilas George; Bafaloukos Dimitrios; Koutsoukou Vasiliki; Pectasides Dimitrios; Skarlos Dimosthenis; Samantas Epaminondas; Kalofonos Haralabos P; Gogas Helen; Pavlidis Nicholas
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Breast cancer research and treatment 2006;97(3):237-44.
-
2006: Murray S; Timotheadou E; Linardou H; Vrettou A V; Kostopoulos I; Skrickova J; Papakostantinou C; Christodoulou C; Pectasides D; Samantas E; Papakostas P; Skarlos D V; Kosmidis P; Fountzilas G
Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 2006;52(2):225-33.
-
2006: Onyenadum A; Gogas H; Kosmidis P; Aravantinos G; Bafaloukos D; Bacoyiannis H; Markopoulos C; Koutras A; Tzorakoelefterakis E; Makatsoris T; Fountzilas G; Kalofonos H P;
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer.
Journal of chemotherapy (Florence, Italy) 2006;18(2):192-8.
-
2006: Kostopoulos Ioannis; Arapantoni-Dadioti Petroula; Gogas Helen; Papadopoulos Savvas; Malamou-Mitsi Vasiliki; Scopa Chrisoula D; Markaki Sofia; Karagianni Evangelia; Kyriakou Vasiliki; Margariti Anastasia; Kyrkou Elisavet; Pavlakis Kitty; Zaramboukas Thomas; Skordalaki Anna; Bourli Antonia; Markopoulos Christos; Pectasides Dimitrios; Dimopoulos Meletios A; Skarlos Dimosthenis; Fountzilas George
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Breast cancer research and treatment 2006;96(3):251-61.
-
2006: Kourea Helen P; Koutras Angelos K; Zolota Vassiliki; Grimani Irene; Tzoracoeleftherakis Evangelos; Koukouras Dimitrios; Fountzilas George; Gogas Helen; Kyriakou Kyriakos; Adamou Adamos; Kalofonos Haralambos P
Expression of p27KIP1, p21WAF1 and p53 does not correlate with prognosis in node-negative invasive ductal carcinoma of the breast.
Anticancer research 2006;26(2B):1657-68.
-
2006: Gogas Helen; Ioannovich John; Dafni Urania; Stavropoulou-Giokas Catherine; Frangia Konstantina; Tsoutsos Dimosthenis; Panagiotou Petros; Polyzos Aristidis; Papadopoulos Othonas; Stratigos Alexandros; Markopoulos Christos; Bafaloukos Dimitrios; Pectasides Dimitrios; Fountzilas George; Kirkwood John M
Prognostic significance of autoimmunity during treatment of melanoma with interferon.
The New England journal of medicine 2006;354(7):709-18.
-
2006: Bamias Aristotle; Moulopoulos Lia A; Koutras Aggelos; Aravantinos Gerassimos; Fountzilas George; Pectasides Dimitris; Kastritis Efstathios; Gika Dimitros; Skarlos Dimosthenis; Linardou Helena; Kalofonos Haralambos P; Dimopoulos Meletios A
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
Cancer 2006;106(2):297-303.
-
2006: Fountzilas George; Pectasides Dimitrios; Christodoulou Christos; Timotheadou Eleni; Economopoulos Theofanis; Papakostas Pavlos; Papadimitriou Christos; Gogas Helen; Efstratiou Ioannis; Skarlos Dimosthenis
Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer.
Medical oncology (Northwood, London, England) 2006;23(4):479-88.
-
2006: Bamias Aristotle; Papadimitriou Christos; Efstathiou Eleni; Rodolakis Alexandros; Vlahos Georgios; Voulgaris Zannis; Bozas Georgios; Fountzilas Georgios; Aravantinos Gerassimos; Razis Evagelia; Gika Dimitra; Dimopoulos Meletios A
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
BMC cancer 2006;6():228.
-
2006: Pentheroudakis G; Razis E; Athanassiadis A; Pavlidis N; Fountzilas G
Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: accumulating evidence for synergy, efficacy, and safety.
Medical oncology (Northwood, London, England) 2006;23(2):147-60.
-
2006: Psyrri Amanda; Fountzilas George
Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region.
Medical oncology (Northwood, London, England) 2006;23(1):1-15.
-
2006: Papakostas Pavlos; Tsavdaridis Dimitrios; Kosmidis Paris; Kalofonos Haralabos P; Sakantamis Athanassios; Janinis Dimitrios; Skarlos Dimosthenis; Bafaloukos Dimitrios; Bamias Aristotelis; Xiros Nikos; Fountzilas George
Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2006;9(1):26-31.
-
2005: Karavasilis Vasilis; Malamou-Mitsi Vasiliki; Briasoulis Evangelos; Tsanou Elena; Kitsou Evangelia; Kalofonos Haralambos; Fountzilas George; Fotsis Theodore; Pavlidis Nicholas
Matrix metalloproteinases in carcinoma of unknown primary.
Cancer 2005;104(10):2282-7.
-
2005: Fountzilas G; Skarlos D; Dafni U; Gogas H; Briasoulis E; Pectasides D; Papadimitriou C; Markopoulos C; Polychronis A; Kalofonos H P; Siafaka V; Kosmidis P; Timotheadou E; Tsavdaridis D; Bafaloukos D; Papakostas P; Razis E; Makrantonakis P; Aravantinos G; Christodoulou C; Dimopoulos A-M
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1762-71.
-
2005: Briasoulis E; Samantas E; Kalofonos H; Skarlos D; Makatsoris T; Christodoulou C; Fountzilas G; Bamias A; Dimopoulos M A; Kosmidis P; Pavlidis N
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Cancer chemotherapy and pharmacology 2005;56(5):521-8.
-
2005: Vlachtsis Konstantinos; Nikolaou Angelos; Markou Konstantinos; Fountzilas George; Daniilidis Ioannis
Clinical and molecular prognostic factors in operable laryngeal cancer.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2005;262(11):890-8.
-
2005: Economopoulos Theofanis; Papageorgiou Sotirios; Rontogianni Dimitra; Kaloutsi Vassiliki; Fountzilas George; Tsatalas Constantinos; Pavlidis Nikolaos; Pectasides Dimitrios; Papageorgiou Efstathios; Dimopoulos Meletios;
Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group study.
The oncologist 2005;10(9):734-8.
-
2005: Pectasides Dimitrios; Aravantinos Gerasimos; Fountzilas George; Kalofonos Charalampos; Efstathiou Eleni; Karina Maria; Pavlidis Nicolaos; Farmakis Dimitrios; Economopoulos Theofanis; Dimopoulos Meletios A
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
Anticancer research 2005;25(5):3553-8.
-
2005: Samelis Georgios Fotios; Kalofonos Haralambos; Adamou Adamos; Kosmides Paris; Skarlos Dimosthenis; Aravantinos Gerasimos; Kiamouris Christos; Adimchi Oneynadum; Fountzilas Georgios; Dimopoulos Athanasios Meletios
The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Urology 2005;66(2):382-5.
-
2005: Papageorgiou Efstathios S; Tsirigotis Panagiotis; Dimopoulos Meletios; Pavlidis Nikolaos; Fountzilas George; Papageorgiou Sotirios; Economopoulos Theofanis;
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group.
European journal of haematology 2005;75(2):124-9.
-
2005: Bruzzi Paolo; Del Mastro Lucia; Sormani Maria P; Bastholt Lars; Danova Marco; Focan Christian; Fountzilas George; Paul James; Rosso Riccardo; Venturini Marco
Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(22):5117-25.
-
2005: Timotheadou Eleni; Papakostas Pavlos; Tsavdaridis Dimitrios; Basdanis George; Kalofonos Haralambos; Aravantinos Gerasimos; Bafaloukos Dimitrios; Fountzilas George
Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the Hellenic Cooperative Oncology Group (HeCOG).
Tumori 2005;91(4):309-13.
-
2005: Skarlos Dimosthenis V; Kalofonos Haralabos P; Fountzilas George; Dimopoulos Meletios A; Pavlidis Nicholas; Razis Evangelia; Economopoulos Theofanis; Pectasides Dimitrios; Gogas Helen; Kosmidis Paris; Bafaloukos Dimitrios; Klouvas George; Kyratzis George; Aravantinos Gerasimos
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.
Anticancer research 2005;25(4):3103-8.
-
2005: Fountzilas George; Pectasides Dimitrios; Kalogera-Fountzila Anna; Skarlos Dimosthenis; Kalofonos Haralambos P; Papadimitriou Christos; Bafaloukos Dimitrios; Lambropoulos Stefanos; Papadopoulos Savvas; Kourea Helen; Markopoulos Christos; Linardou Helen; Mavroudis Dimitrios; Briasoulis Evangelos; Pavlidis Nicholaos; Razis Evangelia; Kosmidis Paraskevas; Gogas Helen
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
Breast cancer research and treatment 2005;92(1):1-9.
-
2005: Aravantinos G; Fountzilas G; Kosmidis P; Dimopoulos M A; Stathopoulos G P; Pavlidis N; Bafaloukos D; Papadimitriou C; Karpathios S; Georgoulias V; Papakostas P; Kalofonos H P; Grimani E; Skarlos D V;
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
-
2005: Kalofonos H P; Aravantinos G; Kosmidis P; Papakostas P; Economopoulos T; Dimopoulos M; Skarlos D; Bamias A; Pectasides D; Chalkidou S; Karina M; Koutras A; Samantas E; Bacoyiannis C; Samelis G F; Basdanis G; Kalfarentzos F; Fountzilas G
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(6):869-77.
-
2005: Bafaloukos D; Tsoutsos D; Kalofonos H; Chalkidou S; Panagiotou P; Linardou E; Briassoulis E; Efstathiou E; Polyzos A; Fountzilas G; Christodoulou C; Kouroussis C; Iconomou T; Gogas H
Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(6):950-7.
-
2005: Pectasides Dimitrios; Fountzilas George; Aravantinos Gerasimos; Kalofonos Haralampos P; Efstathiou Eleni; Salamalekis Emmanouel; Farmakis Dimitrios; Skarlos Dimosthenis; Briasoulis Evangelos; Economopoulos Theofanis; Dimopoulos Meletios A
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2005;97(2):436-41.
-
2005: Fountzilas George; Tolis Christos; Kalogera-Fountzila Anna; Karanikiotis Charisios; Bai Maria; Misailidou Despina; Samantas Epaminodas; Athanassiou Eleni; Papamichael Demetris; Tsekeris Periklis; Catodritis Nikos; Nicolaou Angelos; Plataniotis George; Makatsoris Thomas; Papakostas Pavlos; Zamboglou Nikolaos; Daniilidis John
Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma. A Hellenic Cooperative Oncology Group phase II study.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2005;181(4):223-30.
-
2005: Karavasilis Vasilis; Malamou-Mitsi Vasiliki; Briasoulis Evangelos; Tsanou Elena; Kitsou Evangelia; Kalofonos Haralambos; Fountzilas George; Fotsis Theodore; Pavlidis Nicholas
Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1.
BMC cancer 2005;5():25.
-
2005: Razis E; Skarlos D; Briasoulis E; Dimopoulos M; Fountzilas G; Lambropoulos S; Rigatos S; Kopterides P; Efstathiou H; Tzamakou E; Bakoyannis C; Pectasides D; Makatsoris T; Varthalitis G; Papadopoulos S; Kosmidis P
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program.
Anti-cancer drugs 2005;16(2):191-8.
-
2005: Karanikiotis Charisios; Skiadas Ioannis; Karina Maria; Georgakopoulou Stavroula; Georgakopoulos Eleftherios; Fountzilas George
A novel chromatographic method for Ep-CAM mRNA detection in peripheral blood and bone marrow of patients with metastatic colorectal cancer.
Anticancer research 2005;25(1A):319-23.
-
2005: Apessos A; Mihalatos M; Danielidis I; Kallimanis G; Agnantis N J; Triantafillidis J K; Fountzilas G; Kosmidis P A; Razis E; Georgoulias V A; Nasioulas G
hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.
British journal of cancer 2005;92(2):396-404.
-
2005: Bamias Aristotle; Basdanis George; Xanthakis Ioannis; Pavlidis Nicholas; Fountzilas George
Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy: a pooled analysis of two randomized studies.
International journal of gastrointestinal cancer 2005;36(1):29-38.
-
2005: Fountzilas George; Tolis Christos; Kalogera-Fountzila Anna; Misailidou Despina; Tsekeris Periklis; Karina Maria; Nikolaou Angelos; Samantas Epaminondas; Makatsoris Thomas; Athanassiou Eleni; Skarlos Dimosthenis; Bamias Aristotelis; Zamboglou Nikolas; Economopoulos Theofanis; Karanastassi Sophia; Pavlidis Nicholas; Daniilidis John
Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study.
Medical oncology (Northwood, London, England) 2005;22(3):269-79.
-
2005: Makatsoris Thomas; Kalofonos Haralabos P; Aravantinos Gerasimos; Papadimitriou Christos; Kastritis Efstathios; Rigatos Sotirios K; Xiros Nikolaos; Petsas Theodore; Economopoulos Theofanis; Sakadamis Athanassios K; Fountzilas George;
A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer.
International journal of gastrointestinal cancer 2005;35(2):103-9.
-
2005: Mihalatos Markos; Apessos Angela; Dauwerse Hans; Velissariou Voula; Psychias Aristidis; Koliopanos Alexander; Petropoulos Konstantinos; Triantafillidis John K; Danielidis Ioannis; Fountzilas George; Agnantis Niki J; Nasioulas Georgios
Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients.
BMC cancer 2005;5():40.
-
2005: Economopoulos T; Papageorgiou S; Dimopoulos M A; Pavlidis N; Tsatalas C; Symeonidis A; Foudoulakis A; Pectasides D; Rontogianni D; Rizos E; Chalkia P; Anagnostopoulos A; Melachrinou M; Papageorgiou E; Fountzilas G
Non-Hodgkin's lymphomas in Greece according to the WHO classification of lymphoid neoplasms. A retrospective analysis of 810 cases.
Acta haematologica 2005;113(2):97-103.
-
2005: Pentheroudakis George; Briasoulis Evangelos; Karavassilis Vassilis; Fountzilas George; Xeros Nikolaos; Samelis George; Samantas Epaminondas; Pavlidis Nicholas
Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?
Acta oncologica (Stockholm, Sweden) 2005;44(2):155-60.
-
2004: Giannoulis K; Angouridaki C; Fountzilas G; Papapolychroniadis C; Giannoulis E; Gamvros O
Serum concentrations of soluble ICAM-1 and VCAM-1 in patients with colorectal cancer. Clinical implications.
Techniques in coloproctology 2004;8 Suppl 1():s65-7.
-
2004: Giannoulis K; Fountzilas G; Angouridakis N; Angouridaki C; Giannoulis E; Gamvros O
Serum levels of bcl-2 in patients with colorectal cancer.
Techniques in coloproctology 2004;8 Suppl 1():s56-8.
-
2004: Bafaloukos D; Papadimitriou C; Linardou H; Aravantinos G; Papakostas P; Skarlos D; Kosmidis P; Fountzilas G; Gogas H; Kalofonos C; Dimopoulos A M
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group.
British journal of cancer 2004;91(9):1639-44.
-
2004: Bamias Aristotle; Syrigos Konstantinos; Fountzilas George; Tzamakou Eleftheria; Soulti Kali; Karavasilis Vasilios; Alamanos Yiannis; Christodoulou Christos; Pavlidis Nicholas
Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic study.
American journal of clinical oncology 2004;27(5):465-71.
-
2004: Fountzilas G; Kalofonos H P; Dafni U; Papadimitriou C; Bafaloukos D; Papakostas P; Kalogera-Fountzila A; Gogas H; Aravantinos G; Moulopoulos L A; Economopoulos T; Pectasides D; Maniadakis N; Siafaka V; Briasoulis E; Christodoulou C; Tsavdaridis D; Makrantonakis P; Razis E; Kosmidis P; Skarlos D; Dimopoulos M A
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1517-26.
-
2004: Briasoulis Evangelos; Karavasilis Vasilis; Kostadima Lida; Ignatiadis Michael; Fountzilas George; Pavlidis Nicholas
Metastatic breast carcinoma confined to bone: portrait of a clinical entity.
Cancer 2004;101(7):1524-8.
-
2004: Briasoulis E; Pentheroudakis G; Timotheadou H; Rammou D; Pavlidis N; Fountzilas G
Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I study.
Anti-cancer drugs 2004;15(8):747-52.
-
2004: Pentheroudakis G; Kostadima L; Fountzilas G; Kalogera-Fountzila A; Klouvas G; Kalofonos C; Pavlidis N
Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features.
Lung cancer (Amsterdam, Netherlands) 2004;45(3):349-55.
-
2004: Bafaloukos Dimitros; Tsoutsos Dimosthenis; Fountzilas Georges; Linardou Helen; Christodoulou Christos; Kalofonos Haralambos P; Briassoulis Erangelos; Panagiotou Petros; Hatzichristou Helen; Gogas Helen
The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma.
Melanoma research 2004;14(4):289-94.
-
2004: Plataniotis George A; Theofanopoulou Maria-Ekaterini; Kalogera-Fountzila Anna; Haritanti Afroditi; Ciuleanou Elisabeta; Ghilezan Nicolae; Zamboglou Nikolaos; Dimitriadis Athanasios; Sofroniadis Ioannis; Fountzilas George
Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial.
International journal of radiation oncology, biology, physics 2004;59(4):1018-26.
-
2004: Andreopoulou Eleni; Pectasides Dimitris; Dimopoulos Meletios A; Nikolaides Costas; Fountzilas George; Valsami Serena; Economopoulos Theofanis;
Primary mediastinal large B-cell lymphoma: clinical study of a distinct clinical entity and treatment outcome in 20 patients: review of the literature.
American journal of clinical oncology 2004;27(3):312-6.
-
2004: Bamias A; Deliveliotis Ch; Fountzilas G; Gika D; Anagnostopoulos A; Zorzou M P; Kastritis E; Constantinides C; Kosmidis P; Dimopoulos M A
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2150-4.
-
2004: Janinis Jim; Stathopoulos George P; Nikolaidis Pavlos; Kalofonos Haralambos P; Kalogera-Fountzila Anna; Samantas Epaminondas; Aravantinos Gerasimos; Anagnostopoulos Athanassios; Tolis Christos; Makatsoris Thomas; Rigatos Sotiris K; Bafaloukos Dimitrios; Dimopoulos Meletios A; Daniilidis John; Fountzilas George
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Anti-cancer drugs 2004;15(5):479-87.
-
2004: Gogas Helen; Bafaloukos Dimitrios; Ioannovich John; Skarlos Dimosthenis; Polyzos Aris; Fountzilas George; Kalofonos Haralambos P; Aravantinos Gerassimos; Tsoutsos Dimosthenis; Panagiotou Petros; Frangia Konstantina; Petrakopoulou Theodora; Pectasides Dimitrios;
Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study.
Anticancer research 2004;24(3b):1947-52.
-
2004: Fountzilas George; Stathopoulos G; Kouvatseas G; Polychronis A; Klouvas G; Samantas E; Zamboglou N; Kyriakou K; Adamou A; Pectasidis D; Ekonomopoulos Th; Kalofonos H P; Bafaloukos D; Georgoulias V; Razis E; Koukouras D; Zombolas V; Kosmidis P; Skarlos D; Pavlidis N;
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
American journal of clinical oncology 2004;27(1):57-67.
-
2004: Papadimitriou Christos A; Fountzilas George; Aravantinos Gerassimos; Kalofonos Charalambos; Moulopoulos Lia A; Briassoulis Evangelos; Gika Dimitra; Dimopoulos Meletios-A;
Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study.
Gynecologic oncology 2004;92(1):152-9.
-
2004: Gogas Helen; Bafaloukos D; Aravantinos G; Fountzilas G; Tsoutsos D; Panagiotou P; Frangia K; Kalofonos H P; Briasoulis E; Castana O; Polyzos A; Pectasides D; Ioannovich J;
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
Cancer investigation 2004;22(6):832-9.
-
2004: Fountzilas George; Christodoulou Christos; Tsavdaridis Dimitrios; Kalogera-Fountzila Anna; Aravantinos Gerassimos; Razis Evangelia; Kalofonos Haralambos P; Papakostas Pavlos; Karina Maria; Gogas Helen; Skarlos Dimosthenis
Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Cancer investigation 2004;22(5):655-62.
-
2004: Giannoulis E; Economopoulos T; Mandraveli K; Giannoulis K; Nikolaides C; Zervou E; Papageorgiou E; Zoulas D; Tourkantonis A; Giannopoulos G; Fountzilas G;
The prevalence of hepatitis C and hepatitis G virus infection in patients with B cell non-Hodgkin lymphomas in Greece: a Hellenic Cooperative Oncology Group Study.
Acta haematologica 2004;112(4):189-93.
-
2004: Fountzilas George; Ciuleanu Elisabeta; Dafni Urania; Plataniotis George; Kalogera-Fountzila Anna; Samantas Epaminontas; Athanassiou Eleni; Tzitzikas John; Ciuleanu Tudor; Nikolaou Angelos; Pantelakos Panayiotis; Zaraboukas Thomas; Zamboglou Nikolaos; Daniilidis John; Ghilezan Nicolas
Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study.
Medical oncology (Northwood, London, England) 2004;21(2):95-107.
-
2004: Razis Evangelia; Kosmidis Paris; Aravantinos Gerassimos; Bakoyiannis Charalambos; Janinis Jim; Timotheadou Helen; Christodoulou Christos; Fountzilas George
Second line chemotherapy with 5 fluorouracil and vinorelbine in anthracycline and taxane pretreated patients with metastatic breast cancer.
Cancer investigation 2004;22(1):10-5.
-
2003: Xiros Nikolaos; Economopoulos Theofanis; Valsami Serena; Rontogianni Dimitra; Fountzilas George; Raptis Sotirios
Rituximab in combination with vinorelbine/gemcitabine chemotherapy in patients with primary refractory or early relapsed T cell rich B cell lymphoma. A pilot study.
Leukemia research 2003;27(12):1097-9.
-
2003: Economopoulos T; Fountzilas G; Dimopoulos M A; Papageorgiou S; Xiros N; Kalantzis D; Dervenoulas J; Raptis S
Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study.
European journal of haematology 2003;71(4):257-62.
-
2003: Pectasides Dimitrios; Skarlos Dimosthenis; Dimopoulos Athanasios-Meletios; Farmakis Dimitrios; Pectasides Melina; Fountzilas George; Aravantinos Gerasimos
Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
Anticancer research 2003;23(5b):4239-44.
-
2003: Skarlos Dimosthenis-Vasilios; Dimopoulos Athanassios-Meletios; Kosmidis Paraskevas; Papakostas Pavlos; Pavlidis Nicholas; Bacoyiannis Charalambos; Kiamouris Christos; Klouvas Georgios; Gogas Helen; Fountzilas George; Samantas Epaminondas;
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group.
Lung cancer (Amsterdam, Netherlands) 2003;41(1):107-11.
-
2003: Fountzilas George; Razis Evangelia; Tsavdaridis Dimitrios; Karina Maria; Labropoulos Stefanos; Christodoulou Christos; Mavroudis Dimitrios; Gogas Helen; Georgoulias Vassilios; Skarlos Dimosthenis
Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the hellenic cooperative oncology group.
Clinical breast cancer 2003;4(2):120-5.
-
2003: Mihalatos M; Apessos A; Papadopoulou E; Agnantis N J; Yannoukakos D; Fountzilas G; Nasioulas G
Genetic alterations of the APC gene in familial adenomatous polyposis patients of the hellenic group for the study of colorectal cancer.
Anticancer research 2003;23(3A):2191-3.
-
2003: Mihalatos Markos; Apessos Angela; Triantafillidis John K; Kosmidis Paris A; Fountzilas George; Agnantis Niki J; Yannoukakos Drakoulis; Nasioulas George
Evaluation of dHPLC in mutation screening of the APC gene in a Greek FAP cohort.
Anticancer research 2003;23(3B):2691-5.
-
2003: Kurek Ralf; Kalogera-Fountzila Anna; Muskalla Klaus; Dafni Urania; Schnabel Thomas; Kober Bernhard; Röddiger Sandra; Martin Thomas; Fountzilas George; Zamboglou Nikolaos
Usefulness of tumor volumetry as a prognostic factor of survival in head and neck cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(5):292-7.
-
2003: Gogas H; Fountzilas G
The role of taxanes as a component of neoadjuvant chemotherapy for breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(5):667-74.
-
2003: Razis Evangelia; Fountzilas George
Technology evaluation: TriGem, Titan.
Current opinion in molecular therapeutics 2003;5(2):204-7.
-
2003: Kalofonos Haralabos P; Kardamakis Dimitrios; Bamias Aristotelis; Skarlos Dimosthenis; Papakostas Pavlos; Bafaloukos Dimitrios; Sakantamis Athanasios; Pavlidis Nicolas; Fountzilas Georgios
Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study.
Anticancer research 2003;23(2C):1687-91.
-
2003: Mihalatos M; Danielides I; Belogianni J; Harokopos E; Papadopoulou E; Kalimanis G; Tsiava M; Triantafillidis J K; Kosmidis P A; Fountzilas G; Basdanis G; Agnantis N J; Yannoukakos D; Nasioulas G
Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients.
Cancer genetics and cytogenetics 2003;141(1):65-70.
-
2003: Kalofonos H P; Skarlos D; Bafaloukos D; Papakostas P; Bamias A; Janinis J; Timotheadou E; Kouvatseas G; Stavropoulos M; Economopulos T; Fountzilas G
A phase II study with CPT-11 plus leucovorin and bolus IV 5-fluorouracil in patients with advanced colorectal carcinoma.
Cancer investigation 2003;21(6):855-62.
-
2003: Economopoulos Theofanis; Fountzilas George; Pavlidis Nicholas; Kalantzis Dimitris; Papageorgiou Efstathios; Christodoulou Christos; Hamilos George; Nicolaides Costas; Dimopoulos Meletios
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(2):110-5.
-
2003: Bamias A; Aravantinos G; Kalofonos C; Timotheadou N; Siafaka V; Vlahou I; Janinis D; Pectasides D; Pavlidis N; Fountzilas G;
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group.
Oncology 2003;64(2):102-10.
-
2002: Christodolou C; Pavlidis N; Samantas E; Fountzilas G; Kouvatseas G; Pagdatoglou K; Palamidas F; Nikolaidis C; Angelidou M; Kalofonos H P; Kosmidis P; Skarlos D V
Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study.
Anticancer research 2002;22(6B):3749-57.
-
2002: Pectasides D; Fountzilas G; Rigopoulos A; Bountouroglou N G; Koutras A; Glotsos J; Onyenadum A; Makatsoris Th; Kalofonos H P
Irinotecan and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. A phase II study of the Hellenic Cooperative Oncology Group.
Anticancer research 2002;22(6B):3501-6.
-
2002: Gogas H; Papadimitriou C; Kalofonos H P; Bafaloukos D; Fountzilas G; Tsavdaridis D; Anagnostopoulos A; Onyenadum A; Papakostas P; Economopoulos T; Christodoulou C; Kosmidis P; Markopoulos C
Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(11):1737-42.
-
2002: Ladopoulou A; Kroupis C; Konstantopoulou I; Ioannidou-Mouzaka L; Schofield A C; Pantazidis A; Armaou S; Tsiagas I; Lianidou E; Efstathiou E; Tsionou C; Panopoulos C; Mihalatos M; Nasioulas G; Skarlos D; Haites N E; Fountzilas G; Pandis N; Yannoukakos D
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed.
Cancer letters 2002;185(1):61-70.
-
2002: Kosmidis Paris; Mylonakis Nick; Nicolaides Costas; Kalophonos Charalabos; Samantas Epaminontas; Boukovinas John; Fountzilas George; Skarlos Dimosthenis; Economopoulos Theophanis; Tsavdaridis Dimitrios; Papakostas Pavlos; Bacoyiannis Charalabos; Dimopoulos Meletios
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3578-85.
-
2002: Punt Cornelis J A; Nagy Attila; Douillard Jean-Yves; Figer Arie; Skovsgaard Torben; Monson John; Barone Carlo; Fountzilas George; Riess Hanno; Moylan Eugene; Jones Delyth; Dethling Juergen; Colman Jessica; Coward Lorna; MacGregor Stuart
Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study.
Lancet 2002;360(9334):671-7.
-
2002: Andreopoulou E; Andreopoulos D; Adamidis K; Fountzila-Kalogera A; Fountzilas G; Dimopoulos M A; Aravantinos G; Zamboglou N; Baltas D; Pavlidis N
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer.
Anticancer research 2002;22(3):1903-8.
-
2002: Economopoulos T; Dimopoulos M A; Mellou S; Pavlidis N; Samantas E; Nicolaides C; Tsatalas C; Papadopoulos A; Papageogriou E; Papasavvas P; Fountzilas G
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
European journal of haematology 2002;68(3):135-43.
-
2002: Kalofonos Haralabos P; Nicolaides Costas; Samantas Epaminondas; Mylonakis Nicolaos; Aravantinos Gerasimos; Dimopoulos Meletios A; Gennatas Constantinos; Kouvatseas Georgios; Giannoulis Eleftherios; Dervenis Christos; Basdanis Georgios; Pavlidis Nicolaos; Androulakis Ioannis; Fountzilas Georgios;
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
American journal of clinical oncology 2002;25(1):23-30.
-
2002: Dimopoulos Meletios A; Fountzilas George; Papageorgiou Efstathios; Kiamouris Christos; Mantzios George; Anagnostopoulos Athanassios; Nicolaides Costas; Economopoulos Theofanis;
Primary treatment of low-grade non-Hodgkin's lymphoma with the combination of fludarabine and mitoxantrone: a phase II study of the Hellenic Cooperative Oncology Group.
Leukemia & lymphoma 2002;43(1):111-4.
-
2002: Bafaloukos D; Gogas H; Georgoulias V; Briassoulis E; Fountzilas G; Samantas E; Kalofonos Ch; Skarlos D; Karabelis A; Kosmidis P
Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(2):420-5.
-
2002: Bafaloukos D; Aravantinos G; Fountzilas G; Stathopoulos G; Gogas H; Samonis G; Briasoulis E; Mylonakis N; Skarlos D V; Kosmidis P
Docetaxel in combination with dacarbazine in patients with advanced melanoma.
Oncology 2002;63(4):333-7.
-
2001: Fountzilas G; Tsavdaridis D; Kalogera-Fountzila A; Christodoulou C H; Timotheadou E; Kalofonos C H; Kosmidis P; Adamou A; Papakostas P; Gogas H; Stathopoulos G; Razis E; Bafaloukos D; Skarlos D
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1545-51.
-
2001: Pectasides D; Dimopoulos M A; Aravantinos G; Kalophonos H P; Papacostas P; Briasoulis E; Cogas E; Papadimitriou C; Skarlos D; Kosmidis P; Fountzilas G
First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.
Anticancer research 2001;21(5):3575-80.
-
2001: Skarlos D V; Samantas E; Briassoulis E; Panoussaki E; Pavlidis N; Kalofonos H P; Kardamakis D; Tsiakopoulos E; Kosmidis P; Tsavdaridis D; Tzitzikas J; Tsekeris P; Kouvatseas G; Zamboglou N; Fountzilas G
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(9):1231-8.
-
2001: Pectasides D; Kalofonos H P; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Anticancer research 2001;21(4B):3005-10.
-
2001: Razis E D; Fountzilas G
Paclitaxel: epirubicin in metastatic breast cancer--a review.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):593-8.
-
2001: Fountzilas G; Papadimitriou C; Dafni U; Bafaloukos D; Skarlos D; Moulopoulos L A; Razis E; Kalofonos H P; Aravantinos G; Briassoulis E; Papakostas P; Abela K; Gogas E; Kosmidis P; Pavlidis N; Dimopoulos M A
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2232-9.
-
2001: Briasoulis E; Andreopoulou E; Tolis C F; Bairaktari E; Katsaraki A; Dimopoulos M A; Fountzilas G; Seferiadis C; Pavlidis N
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting.
Cancer 2001;91(5):909-17.
-
2001: Fountzilas G; Papadimitriou C; Aravantinos G; Nicolaides C; Stathopoulos G; Bafaloukos D; Kalofonos H; Ekonomopoulos T; Skarlos D; Pavlidis N; Dimopoulos A M
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer.
Oncology 2001;60(3):214-20.
-
2001: Razis E; Dimopoulos A M; Bafaloukos D; Papadimitriou C; Kalogera-Fountzila A; Kalofonos H; Briassoulis E; Samantas E; Keramopoulos A; Pavlidis N; Kosmidis P; Fountzilas G
Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer.
Cancer investigation 2001;19(2):137-44.
-
2000: Economopoulos T; Dimopoulos M A; Foudoulakis A; Nikolaidis C; Tsatalas C; Pectacides D; Rontogianni D; Papageorgiou E; Fountzilas G
Burkitt's lymphoma in Greek adults. A study of the Hellenic co-operative oncology group.
Leukemia research 2000;24(12):993-8.
-
2000: Samantas E; Kalofonos H; Linardou H; Nicolaides C; Mylonakis N; Fountzilas G; Kosmidis P; Skarlos D
Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(11):1395-7.
-
2000: Konstantopoulou I; Kroupis C; Ladopoulou A; Pantazidis A; Boumba D; Lianidou E S; Petersen M B; Florentin L; Chiotellis E; Nounesis G; Efstathiou E; Skarlos D; Tsionou C; Fountzilas G; Yannoukakos D
BRCA1 mutation analysis in breast/ovarian cancer families from Greece.
Human mutation 2000;16(3):272-3.
-
2000: Briasoulis E; Kalofonos H; Bafaloukos D; Samantas E; Fountzilas G; Xiros N; Skarlos D; Christodoulou C; Kosmidis P; Pavlidis N
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3101-7.
-
2000: Nicolaides C; Dimopoulos M A; Samantas E; Bafaloukos D; Kalofonos C; Fountzilas G; Razi E; Kosmidis P; Pavlidis N
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):873-5.
-
2000: Kosmidis P; Mylonakis N; Skarlos D; Samantas E; Dimopoulos M; Papadimitriou C; Kalophonos C; Pavlidis N; Nikolaidis C; Papaconstantinou C; Fountzilas G
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):799-805.
-
2000: Pectasides D; Economopoulos T; Kouvatseas G; Antoniou A; Zoumbos Z; Aravantinos G; Tsatalas C; Halikia A; Nikolaides C; Kiamouris C; Pappa E; Pavlidis N; Skarlos D; Fountzilas G; Dimopoulos M A
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience.
Oncology 2000;58(4):286-92.
-
2000: Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Papavramidis S; Bousoulegas A; Basdanis G; Giannoulis E; Dokmetzioglou J; Katsohis C; Nenopoulou E; Karvounis N; Briassoulis E; Aravantinos G; Kosmidis P; Skarlos D; Pavlidis N
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Oncology 2000;58(3):227-36.
-
2000: Janinis J; Papakostas P; Samelis G; Skarlos D; Papagianopoulos P; Fountzilas G
Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: a Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):163-7.
-
2000: Kosmidis P; Mylonakis N; Dimopoulos A; Pavlidis N; Fountzilas G; Samantas E; Dimitriadis K; Kalophonos C; Tsavdaridis D; Skarlos D
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group.
Seminars in oncology 2000;27(1 Suppl 2):3-8.
-
2000: Janinis J; Giannakakis T; Athanasiades A; Fountzilas G; Bafaloukos D; Kosmidis P; Nikolaides K; Pavlidis N; Skarlos D
A randomized open-label parallel-group study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study.
Tumori 2000;86(1):37-41.
-
2000: Fountzilas G; Nicolaides C; Bafaloukos D; Kalogera-Fountzila A; Kalofonos H; Samelis G; Aravantinos G; Pavlidis N
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study.
Cancer investigation 2000;18(6):503-9.
-
1999: Aravantinos G; Skarlos D V; Kosmidis P; Georgoulias V; Sgouros I; Bafaloukos D; Androulakis N; Florou S; Fountzilas G
Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy.
Critical reviews in oncology/hematology 1999;32(3):209-19.
-
1999: Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G
Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).
American journal of clinical oncology 1999;22(6):542-9.
-
1999: Dimopoulos M A; Bakoyannis C; Georgoulias V; Papadimitriou C; Moulopoulos L A; Deliveliotis C; Karayannis A; Varkarakis I; Aravantinos G; Zervas A; Pantazopoulos D; Fountzilas G; Bamias A; Kyriakakis Z; Anagnostopoulos A; Giannopoulos A; Kosmidis P
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1385-8.
-
1999: Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Oncology 1999;57(1):1-9.
-
1999: Briasoulis E; Karavasilis V; Anastasopoulos D; Tzamakou E; Fountzilas G; Rammou D; Kostadima V; Pavlidis N
Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):701-6.
-
1999: Fountzilas G; Zisiadis A; Dafni U; Konstantaras C; Hatzitheoharis G; Liaros A; Athanassiou E; Dombros N; Dervenis C; Basdanis G; Gamvros O; Souparis A; Briasoulis E; Samantas E; Kappas A; Kosmidis P; Skarlos D; Pavlidis N
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):671-6.
-
1999: Fountzilas G; Stathopoulos G; Nicolaides C; Kalogera-Fountzila A; Kalofonos H; Nikolaou A; Bacoyiannis C; Samantas E; Papadimitriou C; Kosmidis P; Daniilidis J; Pavlidis N
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):475-8.
-
1999: Papadimitriou C A; Sarris K; Moulopoulos L A; Fountzilas G; Anagnostopoulos A; Voulgaris Z; Gika D; Giannakoulis N; Diakomanolis E; Dimopoulos M A
Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):761-6.
-
1999: Samantas E; Skarlos D V; Pectasides D; Nicolaides P; Kalofonos H; Mylonakis N; Vardoulakis T h; Kosmidis P; Pavlidis N; Fountzilas G
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1999;23(2):159-68.
-
1999: Skarlos D V; Samantas E; Pectasides D; Pavlidis N; Kalofonos C; Klouvas G; Panoussaki E; Tsiakopoulos E; Poulakis N; Fountzilas G
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.
American journal of clinical oncology 1999;22(1):87-93.
-
1999: Fountzilas G; Karavelis A; Capizzello A; Kalogera-Fountzila A; Karkavelas G; Zamboglou N; Selviaridis P; Foroglou G; Tourkantonis A
Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme. A phase II study.
Journal of neuro-oncology 1999;45(2):159-65.
-
1998: Giatromanolaki A; Koukourakis M; Zaramboukas T; Skordalaki A; Arapantoni P; Georgoulias V; Fountzilas G
p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
Anticancer research 1998;18(6B):4685-92.
-
1998: Economopoulos T; Fountzilas G; Kostourou A; Daniilidis J; Pavlidis N; Andreopoulou H; Nicolaou A; Papageorgiou E; Mellou S; Dervenoulas J; Stathakis N
Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: a clinicopathological comparison between tonsillar and non tonsillar lymphomas. (Hellenic co-Operative Oncology Group).
Anticancer research 1998;18(6B):4655-60.
-
1998: Tsavaris N; Fountzilas G; Mylonakis N; Athanassiadis A; Kosmas C; Karakousis C; Bacoyiannis C; Kosmidis P
A randomized comparative study of antiemetic prophylaxis with ondansentron in a single 32-mg loading dose versus 8 mg every 6 h in patients undergoing cisplatin-based chemotherapy.
Oncology 1998;55(6):513-6.
-
1998: Fountzilas G; Nicolaides C; Aravantinos G; Skarlos D; Kosmidis P; Papakostas P; Stathopoulos G P; Kontostolis E; Bafaloukos D; Pavlidis N
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.
Oncology 1998;55(6):508-12.
-
1998: Fountzilas G; Dimopoulos A M; Papadimitriou C; Kalogera-Fountzila A; Aravantinos G; Bafaloukos D; Athanassiades A; Nicolaides C; Keramopoulos A; Pavlidis N; Kosmidis P; Skarlos D
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1031-4.
-
1998: Briasoulis E; Tsavaris N; Fountzilas G; Athanasiadis A; Kosmidis P; Bafaloukos D; Skarlos D; Samantas E; Pavlidis N
Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study.
Oncology 1998;55(5):426-30.
-
1998: Nicolaides C; Fountzilas G; Zoumbos N; Skarlos D; Kosmidis P; Pectasides D; Karabelis A; Giannakakis T; Symeonidis A; Papadopoulos A; Antoniou F; Pavlidis N
Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.
Oncology 1998;55(5):405-15.
-
1998: Dimopoulos M A; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Gynecologic oncology 1998;70(1):70-4.
-
1998: Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
Journal of experimental & clinical cancer research : CR 1998;17(1):71-5.
-
1998: Kalogera-Fountzila A; Kosmidis P; Bacoyiannis C; Nicolaou A; Samantas E; Briassoulis E; Pavlidis N; Skarlos D; Daniilidis J; Fountzilas G
Prognostic factors influencing complete response to treatment and survival of patients with nasopharyngeal cancer.
Anticancer research 1998;18(1B):587-93.
-
1998: Fountzilas G; Athanassiades A; Papadimitriou V; Dimopoulos M A; Bafaloukos D; Aravantinos G; Nicolaides C; Kalofonos H; Papakostas P; Xiros N; Razi E
Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 1):45-8.
-
1998: Bafaloukos D; Fountzilas G; Skarlos D; Pavlidis N; Bakoyiannis C; Karvounis N; Kosmidis P
Subcutaneous low doses of interleukin-2 and recombinant interferon alpha with carboplatin and vinblastine in patients with advanced melanoma.
Oncology 1998;55(1):48-52.
-
1997: Fountzilas G; Athanassiades A; Giannakakis T; Briasoulis E; Bafaloukos D; Kalogera-Fountzila A; Onienaoum A; Kalofonos H; Pectasides D; Andreopoulou E; Bamia C; Kosmidis P; Pavlidis N; Skarlos D
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1213-20.
-
1997: Fountzilas G; Athanassiades A; Kalogera-Fountzila A; Samantas E; Bacoyiannis C; Briassoulis E; Pavlidis N; Kosmidis P; Skarlos D
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-28-S19-32.
-
1997: Fountzilas G; Vasilaros S; Koukouras D; Malamos N; Pectasides D; Adamou A; Nenopoulou E; Kiriakou K; Zouvani I; Katsohis K; Kappas A; Skopa C; Semoglou C; Fahantidis E; Konstantaras C; Vasilaki E; Economopoulos T; Bacoyiannis H; Bafaloukos D; Razi E; Polichronis A; Androulakis G; Papaioannou T; Pavlidis N; Kosmidis P
Prognostic variables in greek patients with stage II breast cancer: a Hellenic Cooperative Oncology Group study.
Anticancer research 1997;17(6D):4681-9.
-
1997: Fountzilas G; Athanassiadis A; Kalogera-Fountzila A; Aravantinos G; Bafaloukos D; Briasoulis E; Dombros N; Ioannidis I; Pavlidis N; Kosmidis P; Skarlos D
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1893-5.
-
1997: Stathopoulos G P; Rigatos S; Papakostas P; Fountzilas G
Effectiveness of paclitaxel and carboplatin combination in heavily pretreated patients with head and neck cancers.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1780-3.
-
1997: Skarlos D V; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos G P; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Seminars in oncology 1997;24(5 Suppl 15):S15-57-S15-61.
-
1997: Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanassiadis A; Pavlidis N; Skarlos D
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized study.
Seminars in oncology 1997;24(4 Suppl 12):S12-30-S12-33.
-
1997: Fountzilas G; Athanassiadis A; Nikolaou A; Kalogera-Fountzila A; Tzitzikas J; Samantas E; Skarlos D; Zamboglou N; Daniilidis J
Accelerated bifractionated radiation with concurrent cisplatin administration in locally advanced head and neck cancer: a feasibility study.
Tumori 1997;83(4):735-9.
-
1997: Kosmidis P A; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Andreopoulou E; Pavlidis N; Skarlos D
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(7):697-9.
-
1997: Fountzilas G; Kosmidis P; Avramidis V; Nikolaou A; Kalogera-Fountzila A; Makrantonakis P; Bacoyiannis C; Samantas E; Skarlos D; Daniilidis J
Long-term survival data and prognostic factors of a complete response to chemotherapy in patients with head and neck cancer treated with platinum-based induction chemotherapy: a Hellenic Co-operative oncology Group study.
Medical and pediatric oncology 1997;28(6):401-10.
-
1997: Fountzilas G; Skarlos D; Athanassiades A; Kalogera-Fountzila A; Samantas E; Bacoyiannis C; Nicolaou A; Dombros N; Briasoulis E; Dinopoulou M; Stathopoulos G; Pavlidis N; Kosmidis P; Daniilidis J
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):451-5.
-
1997: Daniilidis M; Fountzilas G; Fleva A; Daniilidis J; Tourkantonis A
Haplotypes of human leukocyte antigens among patients with nasopharyngeal cancer in Greece.
Oncology 1997;54(3):185-92.
-
1997: Kosmidis P A; Bacoyiannis C; Fountzilas G; Aravantinos G; Tsavaris N; Milathianakis C; Skarlos D
5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):373-8.
-
1997: Fountzilas G; Karavelis A; Makrantonakis P; Selviaridis P; Tzitzikas J; Kalogera-Fountzila A; Hatzibaloglou A; Karkavelas G; Foroglou G; Tourkantonis A
Concurrent radiation and intracarotid cisplatin infusion in malignant gliomas: a feasibility study.
American journal of clinical oncology 1997;20(2):138-42.
-
1997: Nicolaides C; Klouvas G; Fountzilas G; Athanassiadis A; Skarlos D; Samantas E; Kosmidis P; Mylonakis N; Pavlidis N
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG).
Journal of experimental & clinical cancer research : CR 1997;16(1):91-4.
-
1997: Fountzilas G; Athanassiadis A; Samantas E; Skarlos D; Kalogera-Fountzila A; Nikolaou A; Bacoyiannis H; Stathopoulos G; Kosmidis P; Daniilidis J
Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.
Seminars in oncology 1997;24(1 Suppl 2):S2-65-S2-67.
-
1997: Aravantinos G; Skarlos D V; Kosmidis P; Athanassiades A; Bafaloukos D; Giannakakis T; Karpathios S; Fountzilas G
A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group study.
European journal of cancer (Oxford, England : 1990) 1997;33(1):160-3.
-
1997: Skarlos D V; Aravantinos G; Linardou E; Kostakopoulos C A; Kastriotis I; Christodoulou C; Picramenos D; Giannakakis T; Dimopoulos K; Fountzilas G
Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study.
European urology 1997;31(4):420-7.
-
1996: Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Skarlos D
Paclitaxel and carboplatin in inoperable non-small cell lung cancer.
Seminars in oncology 1996;23(6 Suppl 16):68-70.
-
1996: Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Skarlos D
Paclitaxel and carboplatin in nonoperable non-small cell lung cancer.
Seminars in oncology 1996;23(6 Suppl 15):16-8.
-
1996: Kosmidis P A; Tsavaris N; Skarlos D; Theocharis D; Samantas E; Pavlidis N; Briassoulis E; Fountzilas G
Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2682-7.
-
1996: Nikolaou A C; Fountzilas G; Daniilidis I
Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study.
The Journal of laryngology and otology 1996;110(9):857-61.
-
1996: Elisaf M; Bairaktari E; Nicolaides C; Fountzilas G; Tzallas C; Siamopoulos K; Tsolas O; Pavlidis N
The beneficial effect of tamoxifen on serum lipoprotein-A levels: an additional anti-atherogenic property.
Anticancer research 1996;16(5A):2725-8.
-
1996: Kosmidis P; Mylonakis N; Fountzilas G; Pavlidis N; Samantas E; Karabelis A; Kattis K; Skarlos D
A prospective randomized phase III study in non-small-cell lung cancer comparing cisplatin, ifosfamide, vinblastine (VIP) versus cisplatin, ifosfamide and etoposide (VIP-16). Hellenic Co-Operative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):517-20.
-
1996: Karavelis A; Foroglou G; Selviaridis P; Fountzilas G
Intraventricular administration of morphine for control of intractable cancer pain in 90 patients.
Neurosurgery 1996;39(1):57-61; discussion 61-2.
-
1996: Bafaloukos D; Pavlidis N; Fountzilas G; Skarlos D; Klouvas G; Makrantonakis P; Giannakakis T; Tsavaris N; Kosmidis P
Recombinant interferon ALFA-2A in combination with carboplatin, vinblastine, and bleomycin in the treatment of advanced malignant melanoma.
American journal of clinical oncology 1996;19(3):296-300.
-
1996: Fountzilas G; Gossios K; Zisiadis A; Svarna E; Skarlos D; Pavlidis N
Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy.
Medical and pediatric oncology 1996;26(5):305-17.
-
1996: Antoniadis C; Selviaridis P; Zaramboukas T; Fountzilas G
Primary angiosarcoma of the brain: case report.
Neurosurgery 1996;38(3):583-5; discussion 585-6.
-
1996: Skarlos D V; Aravantinos G; Kosmidis P; Pavlidis N; Gennatas K; Beer M; Mylonakis N; Makrantonakis P; Klouvas G; Karpathios S; Linardou H; Konstantaras C; Fountzilas G
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group study.
European journal of cancer (Oxford, England : 1990) 1996;32A(3):421-8.
-
1996: Pavlidis N; Nicolaides C; Athanassiadis A; Beriatou K; Skarlos D; Giannakakis T; Kosmidis P; Karvounis N; Fountzilas G
Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group Study.
Oncology 1996;53(2):159-62.
-
1996: Fountzilas G; Polichronis A; Katsohis K; Gennatas K; Toussis D; Skarlos D; Kosmidis P; Vassilaros S; Semoglou C; Giannakakis T; Fahantidis E; Klouvas G; Tsavaris N; Konstantaras C; Makrantonakis P; Kolotas C; Zamboglou N; Tsiliakos S; Hainoglou D; Mylonakis N; Pavlidis N
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
Oncology 1996;53(2):137-46.
-
1996: Pavlidis N; Nicolaides C; Bairaktari E; Kalef-Ezra J; Athanassiadis A; Seferiadis C; Fountzilas G
Soluble interleukin-2 receptors in patients with advanced colorectal carcinoma.
The International journal of biological markers 1996;11(1):6-11.
-
1996: Fountzilas G; Athanassiades A; Giannakakis T; Bafaloukos D; Karakousis K; Dombros N; Kosmidis P; Skarlos D
A phase II study of paclitaxel in advanced breast cancer resistant to anthracyclines.
European journal of cancer (Oxford, England : 1990) 1996;32A(1):47-51.
-
1996: Fountzilas G; Kosmidis P; Sridhar K S; Kalogera-Fountzila A; Banis K; Dimitriadis A; Avramidis V; Nikolaou A; Zaramboukas T; Skarlos D; Vritsios A; Daniilidis I
Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group study.
Cancer investigation 1996;14(3):189-96.
-
1995: Pavlidis N; Briassoulis E; Bai M; Fountzilas G; Agnantis N
Overexpression of C-myc, Ras and C-erbB-2 oncoproteins in carcinoma of unknown primary origin.
Anticancer research 1995;15(6B):2563-7.
-
1995: Fountzilas G; Skarlos D; Nikolaou A; Kalogera-Fountzila A; Tzitzikas J; Kosmidis P; Makrantonakis P; Samantas E; Karpasitis N; Bacoyiannis H
Radiation and concurrent carboplatin administration in locally advanced head and neck cancer. A Hellenic Cooperative Oncology Group Study.
Tumori 1995;81(5):354-8.
-
1995: Pavlidis N A; Bairaktari E; Kalef-Ezra J; Nicolaides C; Seferiadis C; Fountzilas G
Serum soluble interleukin-2 receptors in epithelial ovarian cancer patients.
The International journal of biological markers 1995;10(2):75-80.
-
1995: Karkavelas G; Mavropoulou S; Fountzilas G; Christoforidou V; Karavelis A; Foroglou G; Papadimitriou C
Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme.
Anticancer research 1995;15(2):531-6.
-
1995: Fountzilas G; Skarlos D; Katsohis C; Pavlidis N; Giannakakis T; Bafaloukos D; Fahantidis E; Klouvas G; Beer M; Kosmidis P
High-dose epirubicin and r-met-hu G-CSF (filgrastim) in the treatment of patients with advanced breast cancer: A Hellenic Cooperative Oncology Group study.
Medical and pediatric oncology 1995;24(1):23-8.
-
1994: Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
Lung cancer (Amsterdam, Netherlands) 1994;11(5-6):353-64.
-
1994: Fountzilas G; Betsis D; Nikopoulos A; Zaramboukas T; Dimitriadis A; Tourkantonis A
Extragonadal choriocarcinoma in a patient with Down syndrome.
American journal of clinical oncology 1994;17(5):452-5.
-
1994: Skarlos D V; Samantas E; Kosmidis P; Fountzilas G; Angelidou M; Palamidas P; Mylonakis N; Provata A; Papadakis E; Klouvas G
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(7):601-7.
-
1994: Fountzilas G; Kosmidis P; Zamboglou N; Nikolaou A; Banis K; Avramidis V; Vritsios A; Daniilidis J
Does substitution of surgery with induction chemotherapy preserve organ function in inoperable head and neck cancer? A retrospective analysis of 73 cases.
Journal of chemotherapy (Florence, Italy) 1994;6(4):272-8.
-
1994: Fountzilas G
Retinoids in the management of head and neck cancer. An update.
Journal of chemotherapy (Florence, Italy) 1994;6(2):127-38.
-
1994: Fountzilas G; Skarlos D; Kosmidis P; Samantas E; Kalogera-Fountzila A; Papaspyrou S; Tzitzikas J; Sridhar K S; Makrantonakis P; Pantelakos P
Radiation therapy and concurrent cisplatin administration in locally advanced head and neck cancer. A Hellenic Co-operative Oncology Group study.
Acta oncologica (Stockholm, Sweden) 1994;33(7):825-30.
-
1994: Fountzilas G; Skarlos D; Giannakakis T; Athanasiades A; Bafaloukos D; Kalogera-Fountzila A; Bamia C; Pavlidis N; Kosmidis P
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(7):965-9.
-
1993: Fountzilas G; Skarlos D; Theoharis D; Giannakakis T; Stathopoulos G
Carboplatin and oral etoposide in the treatment of patients with advanced breast cancer refractory to anthracyclines.
Tumori 1993;79(6):389-92.
-
1993: Pavlidis N A; Klouvas G; Nicolaides C; Karantanas A; Beer M; Fountzilas G
A phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group study.
Lung cancer (Amsterdam, Netherlands) 1993;10(1-2):85-9.
-
1993: Nikolaou A; Daniilidis J; Fountzilas G; Kouloulas A; Sombolos K; Velegrakis G
Supraglottic laryngectomy: experience with 66 patients over 20 years.
The Journal of laryngology and otology 1993;107(9):813-6.
-
1993: Fountzilas G; Zissiadis A
The role of interferons in the treatment of colorectal cancer.
Journal of chemotherapy (Florence, Italy) 1993;5(4):271-7.
-
1993: Skarlos D V; Fountzilas G; Pavlidis N; Beer M; Makrantonakis P; Aravantinos G; Pantelakos P; Tsavaris N; Karpasitis N; Kosmidis P
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) study.
Acta oncologica (Stockholm, Sweden) 1993;32(1):37-41.
-
1992: Pavlidis N; Kosmidis P; Skarlos D; Briassoulis E; Beer M; Theoharis D; Bafaloukos D; Maraveyas A; Fountzilas G
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(8):631-4.
-
1992: Fountzilas G; Kosmidis P; Beer M; Sridhar K S; Banis K; Vritsios A; Daniilidis J
Factors influencing complete response and survival in patients with head and neck cancer treated with platinum-based induction chemotherapy. A Hellenic Co-operative Oncology Group Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(7):553-8.
-
1992: Daniilidis J; Nikolaou A; Fountzilas G; Sombolos K
Vertical partial laryngectomy: our results after treating 81 cases of T2 and T3 laryngeal carcinomas.
The Journal of laryngology and otology 1992;106(4):349-52.
-
1992: Fountzilas G; Afthonidis D; Geleris P; Salem N; Kottas G; Halkidis C; Apostolidis P; Beer M; Tourkantonis A
Cardiotoxicity evaluation in patients treated with a mitoxantrone combination as adjuvant chemotherapy for breast cancer.
Anticancer research 1992;12(1):231-4.
-
1992: Economopoulos T; Asprou N; Stathakis N; Fountzilas G; Pavlidis N; Papaspyrou S; Dervenoulas J; Belia M; Papageorgiou E; Theoharis D
Primary extranodal non-Hodgkin's lymphoma of the head and neck.
Oncology 1992;49(6):484-8.
-
1991: Nikolaou A; Fountzilas G; Kosmidis P; Banis C; Sobolos K; Daniilidis J
Laryngeal preservation in cases of advanced laryngeal cancer treated with platinum based induction chemotherapy before local treatment.
The Journal of laryngology and otology 1991;105(11):930-3.
-
1991: Fountzilas G; Kosmidis P; Makrantonakis P; Sridhar K S; Banis K; Themelis C; Kalogera-Fountzila A; Avramidis V; Beer M; Sombolos K
Carboplatin, continuous infusion fluorouracil and mid-cycle high-dose methotrexate as initial treatment in patients with locally advanced head and neck cancer. Hellenic Co-operative Oncology Group Study.
Tumori 1991;77(5):426-31.
-
1991: Fountzilas G; Daniilidis J; Kosmidis P; Sridhar K S; Kalogera-Fountzila A; Banis K; Avramidis V; Tsavdaridis D; Themelis C; Zaramboukas T
Platinum-based induction chemotherapy followed by radiation as definitive treatment for patients with locally advanced cancer of the oral cavity, oropharynx and hypopharynx. A retrospective analysis of 32 cases.
Journal of chemotherapy (Florence, Italy) 1991;3(3):183-8.
-
1991: Fountzilas G; Skarlos D; Pavlidis N A; Makrantonakis P; Tsavaris N; Kalogera-Fountzila A; Giannakakis T; Beer M; Kosmidis P
High-dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Co-operative Oncology Group study.
Tumori 1991;77(3):232-6.
-
1991: Fountzilas G; Zisiadis A; Kosmidis P; Basdanis G; Makrantonakis P; Paspatis A; Tsavdaridis D; Tsavaris N; Aletras O; Tourkantonis A
High-dose leucovorin, fluorouracil and oral dipyridamole in the treatment of advanced colorectal cancer.
Anticancer research 1991;11(2):865-8.
-
1991: Fountzilas G; Daniilidis J; Kosmidis P; Sridhar K S; Kalogera-Fountzila A; Nicolaou A; Makrantonakis P; Banis K; Dimitriadis A; Sombolos K
Platinum-based chemotherapy followed by radiation therapy of locally advanced nasopharyngeal cancer. A retrospective analysis of 39 cases.
Acta oncologica (Stockholm, Sweden) 1991;30(7):831-4.
-
1990: Fountzilas G; Daniilidis J; Sridhar K S; Kalogera-Fountzila A; Zaramboukas T; Sombolos K; Destouni-Salem E; Vritsios A; Tourkantonis A
Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
Cancer 1990;66(7):1453-60.
-
1989: Fountzilas G; Nicolaou A; Sridhar K; Sideras T; Haritanti A; Anastasakis C; Delis V; Vritsios A; Daniilidis J
Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck.
Archives of oto-rhino-laryngology 1989;246(5):373-7.
-
1988: Fountzilas G; Daniilidis J; Kalogera-Fountzila A; Apostolidis T; Vritsios A; Tourkantonis A
[Combined therapy of locally advanced squamous epithelial cancers in the area of the head and neck]
Laryngologie, Rhinologie, Otologie 1988;67(4):165-70.
-
1987: Kosmidis P A; Fountzilas G; Athanassiou A; Karabelis A; Mylonakis N; Tsavaris N; Karvounis N; Bacojiannis C
Combination chemotherapy with prednimustine, adriamycin, vincristine (VAP) in advanced breast cancer. A phase II study.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(6):393-5.
Sign-in to see more